findmyKOL

Mohanram Narayanan, MD

Basic profile

Baylor Scott & White Medical Center - Temple

ORCIDNPI
RegionTemple, TX · South CentralSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Mohanram Narayanan is a Nephrology physician affiliated with Baylor Scott & White Medical Center - Temple. OpenAlex indexes 45 publications with 1,899 citations (h-index 16).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
45publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,899citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
27companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2401 S 31st St
Temple, TX 765080001

Telephone

254-724-2111

Provider last certified this registry record 7 Jan 2021.

View the NPPES registry record

Industry payments

27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    51.9%
    Statin15.8%
    Atorvastatin Calcium66%Rosuvastatin Calcium12%Simvastatin12%Pravastatin Sodium9%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)8.1%
    Losartan Potassium81%Valsartan12%Olmesartan Medoxomil8%
    Part D<11 patients

    + 10 more classes in this area

  • Metabolism & gastrointestinal

    28.3%
    Corticosteroid11%
    Prednisone100%
    Part D52 patients
    SGLT2 inhibitor8.4%
    Farxiga58%Jardiance42%
    Part D27 patients

    + 7 more classes in this area

  • Musculoskeletal

    9.5%
    Xanthine oxidase inhibitor8.6%
    Allopurinol100%
    Part D56 patients
    Bisphosphonates0.9%
    Risedronate Sodium100%
    Part D<11 patients
Where care is delivered (Part B)46.4% facility · 53.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”